Lexaria gets ethics board okay for oral GLP-1 study

on MSN ago, source:

Lexaria Bioscience (NASDAQ:LEXX) said a third-party ethics review board has approved a human pilot study evaluating GLP-1 ...

Lexaria Bioscience Corp. (LEXX)

6d ago, source: Yahoo Finance

Human Pilot Study #2 (GLP-1-H24-2) Approved KELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or ...

Lexaria Bioscience ethics review board approval to begin new GLP-1 study

7d ago, source: Pharmabiz

Lexaria Bioscience ethics review board approval to begin new GLP-1 study: Kelowna, BC Thursday, April 18, 2024, 18:00 Hrs [IST] Lexaria Bioscience Corp., a global innovator in dru ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone With Ethics Review Board Approval

3d ago, source:

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio To 41 Maintains Focus On GLP-1 Clinical Studies For 2024

9d ago, source:

Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to 41 <li /> T ...

Lexaria Bioscience Corp (LEXX) Stock: A SWOT Analysis

10d ago, source: newsheater

In a nutshell, Lexaria Bioscience Corp (LEXX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the ...

Lexaria Bioscience Corp. Wt

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Lexaria Bioscience Corp LEXX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lexaria Bioscience Corp. (LEXX)

8d ago, source: Yahoo Finance

Human Pilot Study #2 (GLP-1-H24-2) Approved KELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or ...

Lexaria Bioscience Corp (LEXX)

3d ago, source: Investing

Clinical study will evaluate safety and tolerability of Lexaria's patented DehydraTECH-CBD as a potential treatment for hypertension California-based InClin to provide CRO services ...

Lexaria Bioscience Corp LEXX

21d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lexaria Bioscience Corp (LEXX)

23d ago, source: Investing

Kelowna, British Columbia, Mar 14, 2024 - (NewMediaWire) - - Lexaria Bioscience Corp. (Nasdaq: NASDAQ:LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global ...